����̽��

Tobacco harm reduction is a public health strategy that is about minimising the negative health impact of conventional cigarettes – including by offering smokers who would not otherwise give up smoking an alternative source of nicotine with potentially lower health risks.

��

We’ve invested more than US$2.5 billion on our Next Generation Products to date, and our commitment to the future is larger still.��

��

Our factsheet provides a short summary of what tobacco harm reduction is, the role that ����̽��has in it, as well as giving a snapshot of what some health bodies and scientific organisations have to say on the topic.

��

David O’Reilly, BAT’s Group Scientific and R&D Director��says: “Tobacco harm reduction is a fundamentally important part of our Group strategy. It underpins the whole of Transforming Tobacco.”